Javascript must be enabled to continue!
Bilateral ONJ in a patient affected by metastatic prostate adenocarcinoma.
View through CrossRef
We present the diagnosis and management of a case of bilateral ONJ of the mandible in a patient that had been taking zoledronic acid treatment for 7 years following a diagnosis of metastatic prostate adenocarcinoma.
The patient was referred to our Division by his dental practitioner, that had performed the extraction of the left lower first molar six months before. In the first months after the extraction the patient did not reported any symptom and he started to use a mandibular removable prosthesis.
About 5 months following the extraction, the patient started to complain of pain in correspondence of the left body region. He had performed a panoramic radiograph and a CT scan showing a possible initial stage of mandibular ONJ bilaterally, with a predominance in the left mandibular body in the post-extraction socket.
Therefore, a curettage of the left mandibular body was decided. Postoperative course was uneventful.
Twelve months later, the patient complained of pain in the right mandibular region and in correspondence of the residual right lower third molar. A panoramic radiograph confirmed the extension of mandibular right ONJ. A curettage of the right mandibular body, together with the removal of the right lower third molar, was performed, with a following uneventful postoperative course.
Two years later, the patient complained of pain in the left mandibular region in correspondence of the residual left lower second premolar. A panoramic radiograph confirmed the extension of mandibular left ONJ with involvement of the root of the aforementioned premolar. A curettage of the right mandibular body, together with the removal of the left lower second premolar, was performed, with a following uneventful postoperative course. Three years later, a complete healing was obtained.
Title: Bilateral ONJ in a patient affected by metastatic prostate adenocarcinoma.
Description:
We present the diagnosis and management of a case of bilateral ONJ of the mandible in a patient that had been taking zoledronic acid treatment for 7 years following a diagnosis of metastatic prostate adenocarcinoma.
The patient was referred to our Division by his dental practitioner, that had performed the extraction of the left lower first molar six months before.
In the first months after the extraction the patient did not reported any symptom and he started to use a mandibular removable prosthesis.
About 5 months following the extraction, the patient started to complain of pain in correspondence of the left body region.
He had performed a panoramic radiograph and a CT scan showing a possible initial stage of mandibular ONJ bilaterally, with a predominance in the left mandibular body in the post-extraction socket.
Therefore, a curettage of the left mandibular body was decided.
Postoperative course was uneventful.
Twelve months later, the patient complained of pain in the right mandibular region and in correspondence of the residual right lower third molar.
A panoramic radiograph confirmed the extension of mandibular right ONJ.
A curettage of the right mandibular body, together with the removal of the right lower third molar, was performed, with a following uneventful postoperative course.
Two years later, the patient complained of pain in the left mandibular region in correspondence of the residual left lower second premolar.
A panoramic radiograph confirmed the extension of mandibular left ONJ with involvement of the root of the aforementioned premolar.
A curettage of the right mandibular body, together with the removal of the left lower second premolar, was performed, with a following uneventful postoperative course.
Three years later, a complete healing was obtained.
Related Results
Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab: A Case Series from the FDA Adverse Event Reporting System (FAERS) Database
Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab: A Case Series from the FDA Adverse Event Reporting System (FAERS) Database
Abstract
Introduction:
Osteonecrosis of the jaw (ONJ) is a rare but serious adverse drug reaction (ADR) historically associated with denosumab and bisphosphonate therapy. S...
Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies.
Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies.
Survival of cancer and myeloma patients after diagnosis of medication-related Osteonecrosis of Jaws (ONJ) has not adequately been reported. ONJ is not rare in patients with bone me...
A web site page for information about Osteonecrosis of Jaw (ONJ): the Rete Oncologica Piemonte e Valle d'Aosta experience, at www.reteoncologica.it
A web site page for information about Osteonecrosis of Jaw (ONJ): the Rete Oncologica Piemonte e Valle d'Aosta experience, at www.reteoncologica.it
Osteonecrosis of the Jaw (ONJ) related to drugs (bisphosphonates, denosumab, antiangiogenic and other agents) is an issue of care by the “Rete Oncologica di Piemonte e Valle d’Aost...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Medication-Induced Osteonecrosis of the Jaw: A Review of Cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
Medication-Induced Osteonecrosis of the Jaw: A Review of Cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
Abstract
Introduction:Osteonecrosis of the jaw (ONJ) is a rare but serious adverse drug reaction (ADR) commonly associated with bisphosphonate and denosumab therapy. Prior ...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...

